Immage Financial Statements From 2010 to 2024
Immage Biotherapeutics financial statements provide useful quarterly and yearly information to potential Immage Biotherapeutics Corp investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Immage Biotherapeutics financial statements helps investors assess Immage Biotherapeutics' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Immage Biotherapeutics' valuation are summarized below:Immage Biotherapeutics Corp does not presently have any fundamental trends for analysis.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
Check Immage Biotherapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Immage Biotherapeutics' main balance sheet or income statement drivers, such as , as well as many indicators such as . Immage financial statements analysis is a perfect complement when working with Immage Biotherapeutics Valuation or Volatility modules.
Immage |
Immage Biotherapeutics Corp Company Current Valuation Analysis
Immage Biotherapeutics' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Immage Biotherapeutics Current Valuation | 32.93 K |
Most of Immage Biotherapeutics' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Immage Biotherapeutics Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CompetitionIn accordance with the recently published financial statements, Immage Biotherapeutics Corp has a Current Valuation of 32.93 K. This is much higher than that of the sector and significantly higher than that of the Current Valuation industry. The current valuation for all United States stocks is notably lower than that of the firm.
Immage Biotherapeutics Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Immage Biotherapeutics's current stock value. Our valuation model uses many indicators to compare Immage Biotherapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Immage Biotherapeutics competition to find correlations between indicators driving Immage Biotherapeutics's intrinsic value. More Info.Immage Biotherapeutics Corp is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Immage Biotherapeutics by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.About Immage Biotherapeutics Financial Statements
Immage Biotherapeutics stakeholders use historical fundamental indicators, such as Immage Biotherapeutics' revenue or net income, to determine how well the company is positioned to perform in the future. Although Immage Biotherapeutics investors may analyze each financial statement separately, they are all interrelated. For example, changes in Immage Biotherapeutics' assets and liabilities are reflected in the revenues and expenses on Immage Biotherapeutics' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Immage Biotherapeutics Corp. Please read more on our technical analysis and fundamental analysis pages.
Immage Biotherapeutics Corp. does not have significant business operations. Immage Biotherapeutics Corp. is a subsidiary of Coventry International Limited. IMMAGE BIOTHERAPEUTICS is traded on OTC Exchange in the United States.
Currently Active Assets on Macroaxis
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Consideration for investing in Immage Stock
If you are still planning to invest in Immage Biotherapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Immage Biotherapeutics' history and understand the potential risks before investing.
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |